Here, we report findings from our study to identify differences in global gene expression between DiFi human colorectal cancer cells; DiFi5, a DiFi subline with acquired resistance to cetuximab; and DiFi-AG, a DiFi subline with acquired resistance to an EGFR tyrosine kinase inhibitor (TKI). Here, EGFR is linked to colorectal cancer.